SEARCH

SEARCH BY CITATION

References

  • 1
    Khinchi MS, Poulsen LK, Carat F, André C, Hansen AB, Malling HJ. Clinical efficacy of sublingual and subcutaneous birch pollen allergen specific immunotherapy: a randomized placebo-controlled, double blind, double dummy study. Allergy 2004;59:4553.
  • 2
    Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2007;119:780791.
  • 3
    Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 2010;8:CD001186.
  • 4
    Eng PA, Reinhold M, Gnehm HP. Long-term efficacy of preseasonal grass polen immunotherapy in children. Allergy 2002;57:306312.
  • 5
    Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Høst A et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10- year follow up on the PAT study. Allergy 2007;62:943948.
  • 6
    Barlan IB, Bahceciler N, Akdis M, Akdis CA. Role of bacillus Calmette-Guérin as an immunomodulator for the prevention and treatment of allergy and asthma. Curr Opin Allergy Clin Immunol 2005;5:552557.
  • 7
    Larché M. Peptide and recombinant immunotherapy. Immunol Allergy Clin North Am 2011;31:377389.
  • 8
    Tsoukas CD, Provvedini DM, Manolagas SC. 1,25-Dihydroxyvitamin D3: a novel immunoregulatory hormone. Science 1984;224:14381440.
  • 9
    Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci U S A 1988;85:32943298.
  • 10
    Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:17701773.
  • 11
    Martineau AR, Wilkinson KA, Newton SM, Wenzel L, Tan BH, Krutzik SR et al. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol 2007;178:71907198.
  • 12
    Searing DA, Leung DY. Vitamin D in atopic dermatitis, asthma and allergic diseases. Immunol Allergy Clin North Am 2010;30:397409.
  • 13
    Penna G, Adorini L. 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000;164:24052411.
  • 14
    Xystrakis E, Kusumakar S, Boswell S, Peek E, Urry Z, Richards DF et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 2006;116:146155.
  • 15
    Urry Z, Xystrakis E, Richards DF, McDonald J, Sattar Z, Cousins DJ et al. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function. J Clin Invest 2009;119:387398.
  • 16
    Taher YA, van Esch BC, Hofman GA, Henricks PA, van Oosterhout AJ. 1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta. J Immunol 2008;180:52115221.
  • 17
    National Institutes of Health. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention Revision, 2010. http://www.ginaasthma.org.
  • 18
    Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M; Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008;122:398417.
  • 19
    Karagiannidis C, Akdis M, Holopainen P, Woolley NJ, Hense G, Rückert B et al. Glucocorticoid supregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004;114:14251433.
  • 20
    Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M et al. 1, 25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009;183:54585467.
  • 21
    Keles S, Karakoc-Aydiner E, Ozen A, Izgi AG, Tevetoglu A, Akkoc T et al. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes. J Allergy Clin Immunol 2011;128:808815.
  • 22
    Majak P, Rychlik B, Stelmach I. The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clin Exp Allergy 2009;39:18301841.
  • 23
    Searing DA, Zhang Y, Murphy JR, Hauk PJ, Goleva E, Leung DY. Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J Allergy Clin Immunol 2010;125:9951000.
  • 24
    Brehm JM, Celedón JC, Soto-Quiros ME, Avila L, Hunninghake GM, Forno E et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med 2009;179:765771.
  • 25
    Bener A, Ehlayel MS, Tulic MK, Hamid Q. Vitamin D deficiency as a strong predictor of asthma in children. Int Arch Allergy Immunol 2012;157:168175.
  • 26
    Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW et al. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 2008;181:70907099.
  • 27
    Hansdottir S, Monick MM, Lovan N, Powers L, Gerke A, Hunninghake GW. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol 2010;184:965974.
  • 28
    Brehm JM, Schuemann B, Fuhlbrigge AL, Hollis BW, Strunk RC, Zeiger RS et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol 2010;126:5258.